omniture

Mindray Medical Announces Pricing of Secondary Offering

Mindray Medical International Limited
2007-02-01 20:01 2368

SHENZHEN, China, Feb. 1 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China, today announced the pricing of its secondary offering of 9,827,220 American Depositary Shares ("ADSs") at US$24.50 per ADS. Each ADS represents one Class A ordinary share, par value HK$0.001 per share, of Mindray. All of the ADSs in this offering are being offered and sold by the selling shareholders of Mindray. Mindray will not receive any proceeds from the sale of the ADSs in this offering.

Goldman Sachs (Asia) L.L.C., J.P. Morgan Securities Inc. and UBS AG are acting as the joint bookrunners for this offering. The underwriters have a 30-day option to purchase up to an additional 1,474,083 ADSs from the selling shareholders in this offering.

A registration statement relating to these securities has been filed with, and declared effective by, the Securities and Exchange Commission. This news release shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities law of any such state or jurisdiction. A copy of the prospectus relating to the offering may be obtained from Goldman, Sachs & Co., c/o Prospectus Department, 85 Broad Street, New York, NY 10004, fax number: 212-902-9316, email: prospectus-ny@ny.email.gs.com; J.P. Morgan Securities Inc., Attention: Prospectus Department, 4 Chase Metrotech Center, CS Level, Brooklyn, NY 11245, telephone number: 718-242-8002, fax number: 718-242-8003; or UBS Investment Bank, Prospectus Department, c/o Clint Lauriston, 299 Park Avenue, New York, NY 10171, telephone number: 212-821-3884, fax number: 212-821-3285, email: clint.lauriston@ubs.com .

About Mindray

Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices in China with a significant and growing presence outside of China. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems. Mindray is headquartered in Shenzhen, China, and has 29 local sales and services offices in China, as well as sales and services offices in Boston, Istanbul, London and Vancouver. For more information, please visit http://www.mindray.com .

For more information, please contact:

In China:

Investor Relations

Mindray Medical International Limited

Tel: +86-755-2658-2518

Email: IR@mindray.com

Philip Lisio

Ogilvy Public Relations Worldwide (Beijing)

Tel: +86-10-8520-6688

Email: Philip.lisio@ogilvy.com

In U.S.:

Thomas Smith

Ogilvy Public Relations Worldwide (New York)

Tel: +1-212-880-5269

Source: Mindray Medical International Limited
collection